Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 9 (1), 294-319

Science, Names Giving and Names Calling: Change NDM-1 to PCM

Affiliations

Science, Names Giving and Names Calling: Change NDM-1 to PCM

Ajai R Singh. Mens Sana Monogr.

Abstract

A journal editor recently apologised for publishing a 2010 paper in which authors designated an enzyme as New Delhi metallo-β-lactamase-1 (NDM-1) and its related gene bla(NDM-1) after a city, New Delhi. This name had raised an outcry in India, with health authorities, media and medical practitioners demanding New Delhi be dropped from the name. The name was actually first given in another 2009 paper, whose corresponding author remains the same as the 2010 paper. There is a tradition of eponymous names in science. But those found derogatory to races, groups, cities, and countries have been changed. For example, "Mongolism" was changed to Down's syndrome; "Australia" antigen to HBsAg; "Mexican" Swine flu to H1N1; "GRID" (Gay Related Immune Deficiency) and 4H-Disease (Haitians, Homosexuals, Haemophiliacs and Heroin Users Disease) to AIDS. It is necessary that NDM-1 also be changed to a name based on scientific characteristics. NDM-1 must be changed to PCM (plasmid-encoding carbapenem-resistant metallo-β-lactamase). It is also necessary to review the tradition of naming organisms, diseases, genes, etc. after cities, countries and races. Often, such names giving amounts to names calling. It needs to be discarded by scientists in all new names giving from now on. "Geographical" and "racial" names giving must be replaced by "scientific" names giving. Journal editors must ensure that such scientific names giving is laid down as standard guideline in paper submissions. All such names still in currency need to be phased out by replacing them with names based on scientific characteristics, or in honour of their pioneering scientist/s or institutions. The lead author of the above 2010 paper has said he was not consulted about the final draft and did not agree with the conclusions of the paper. To ensure that corresponding authors do not ride roughshod over co-authors, and lead and other authors do not backtrack on papers, editors must ensure written concurrence of all authors, especially the lead author, to the final draft of a paper and include this in their guidelines for paper submissions.

Keywords: Carbapenems; Eponymous names; Journal editors; Metallo-β-lactamase; NDM-1; Names changing; Names giving; PCM; Plasmids; Scientific names giving; Submission guidelines; Superbug.

Conflict of interest statement

Conflict of Interest

None declared.

Figures

Figure 1
Figure 1
Flowchart of paper

Similar articles

See all similar articles

Cited by 11 PubMed Central articles

See all "Cited by" articles

References

    1. AFP, (2010), Belgian man dies of South Asian superbug, AFP, Aug 13. 2010. Available at: http://www.google.com/hostednews/afp/article/ALeqM5g2UVNIO5tUQAqbWeE7l2PjSW34cg [Accessed 14 Jan 2011]
    1. AFP/wk, (2010), Japan detects its first case of NDM-1 superbug, Asia Pacific News. Channel NewsAsia. Available at: http://www.channelnewsasia.com/stories/afp_asiapacific/view/1079453/1/.html [Accessed 14 Jan 2011]
    1. Abdul Ghafur K. An obituary- On the Death of antibiotics! Journal of Association of Physicians of India. 2010;58:143–144. Available at: http://www.japi.org/march_2010/article_01.html [Accessed 14 Jan 2011] - PubMed
    1. Alazraki M. GlaxoSmithKline Finds Compound That Could Help Fight ‘Superbugs’. Daily finance. 6 August 2010. Available at: http://www.dailyfinance.com/story/glaxosmithkline-finds-compound-fight-superbugs/19582888/. [Accessed 15 Jan 2011.]
    1. Bonomo R.A. New Delhi Metallo-{beta}-Lactamase and Multidrug Resistance: A Global SOS? Clinical Infectious Diseases. 2011;52:485–487. - PubMed
Feedback